Bio/Pharma Strength, Did Moderna MRNA +129.20% Drive It?
픽스톡AI 요약
The theme to watch before market open is bio/pharma.
The 5-day theme strength is +9.03%, ranking 3rd out of 100 themes.
The key question is whether Moderna (MRNA) leadership will spread to laggards after the open.
This note is not a buy signal, it is a checklist at 08:40 that should be rechecked against intraday news and flows.
TL;DR
Pre-market theme to check: Bio/Pharma
5-day theme average move: +9.03%, 3rd of 100 themes
Notable recent outperformer: Moderna (MRNA) +129.20%
Why watch bio/pharma before the open
The bio/pharma theme comprises companies researching, developing, and producing new drugs, biosimilars, vaccines, diagnostics, and biotech-based therapies.
This theme shows high price volatility tied to clinical results, approvals, licensing, and pipeline updates, while offering longer term growth potential.
08:40 is a useful time to narrow focus before orders, and this note lists which news and flow signals to watch intraday rather than a buy trigger.
Intraday checkpoints today
Check if prior strength holds: confirm whether bio/pharma names remain stronger than the theme average after the open.
Leader to laggard spread: check whether gains are limited to the leaders or extend to second and third tier names.
News plus volume confirmation: moves accompanied by volume are more meaningful than isolated gap moves.
Related stocks to monitor
| Stock | Market | Recent move | Checkpoint |
|---|---|---|---|
| Hanmi Pharmaceutical (128940) | KOSPI | +29.96% | An R&D focused pharma known for new drug development and global licensing out. |
| BioStem Technologies, Inc. (BSEM) | NASDAQ | +10.73% | A healthcare company developing biomaterials and therapeutic products for regenerative medicine. |
| LG Chem (051910) | KOSPI | +8.12% | Operates advanced biopharmaceutical materials and API business and holds a biohealthcare portfolio. |
| Green Cross (006280) | KOSPI | +6.72% | Traditional pharma producing vaccines, blood products, and pharmaceuticals with strengths in vaccines and blood products. |
| SK Bioscience (302440) | KOSPI | +4.93% | Vaccine development and manufacturing specialist, participant in COVID-19 vaccine development and vaccine CDMO business. |
| Celltrion Pharm (068760) | KOSPI | +3.01% | Responsible for manufacturing and selling pharma and bio products within the Celltrion group, with pipeline and commercialization as core. |
Risks
If the bio/pharma theme has already run up, it is important to see whether volume holds during pullbacks rather than chasing the opening price.
Early theme strength can flip quickly, so check alongside index direction, FX, and US futures.
Confirm whether laggards that were weak over the last 5 sessions, such as Afnimed (APMD) -11.72%, show intraday recovery.
Further reading
- View bio/pharma related and leading stocks
- Market wide flow today: PickStock Insight
- Expand the theme yourself: Mindmap
Published: 2026-08-25 08:40 KST. Data source: PickStock theme DB, Yahoo Finance price cache. Auto generated after outlier removal, informational only and not investment advice.
관련 테마의 대표 기업을 확인하고, 내 관심 종목은 뉴스·시그널·시장 맥락으로 이어서 볼 수 있습니다.
종목명을 입력하면 재무, 뉴스, 시장 데이터를 정보 제공용 점검 리포트로 정리합니다.
관심 테마로 저장하면 마이페이지에서 다시 볼 수 있고, 강한 움직임이 생길 때 주간 테마 시그널과 연결해 확인할 수 있습니다.
